Market Scenario
The
global apheresis
market size is projected to grow at a 8.90 % CAGR during the forecast
period (2023-2030). The apheresis market is witnessing significant growth
globally, driven by advancements in technology, increasing prevalence of
chronic diseases, and rising demand for blood components and plasma-derived
therapies. Apheresis, a medical procedure involving the separation and
extraction of blood components such as plasma, platelets, or white blood cells,
plays a crucial role in treating various conditions including autoimmune disorders,
neurological diseases, and hematologic malignancies. The market is
characterized by a growing number of applications, including therapeutic
apheresis for treating diseases like leukemia and myasthenia gravis, as well as
the collection of blood components for transfusion and research purposes.
Technological
innovations and the introduction of automated apheresis systems are driving
market expansion, offering improved efficiency, reduced procedure times, and
enhanced safety for patients. Moreover, the increasing demand for personalized
medicine and targeted therapies is expected to fuel further market growth as
apheresis procedures enable the precise extraction and manipulation of specific
blood components tailored to individual patient needs. With a rising emphasis
on blood safety and the growing adoption of apheresis procedures in both
developed and developing regions, the global apheresis market is projected to
continue its upward trajectory in the coming years, presenting lucrative
opportunities for market players and healthcare providers alike.
The
Apheresis market is witnessing significant growth, driven by the increasing
adoption of advanced therapeutic procedures such as selective plasma filtration
and plasma pheresis. Selective
plasma filtration is a cutting-edge technique that allows for the
precise removal of targeted substances from the blood, offering a tailored
approach to treating various medical conditions. This process involves
separating plasma from blood cells, passing it through a specialized filter to
remove specific components, and then returning the purified plasma back to the
patient's circulation. By selectively removing harmful substances while
preserving essential blood components, selective plasma filtration has emerged
as a promising tool in the treatment of autoimmune disorders, neurological
diseases, and certain cancers.
Competitive Dashboard
The
major players operating the global market are Kaneka Corporation (Japan),
Terumo BCT Inc. (US), Fresenius Medical Care (Germany), Nikkiso Co. Ltd.
(Japan), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany),
Nikkiso Ltd. (Japan), HemaCare Corporation (US), Cerus Corporation (US),
Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), Therakos,
Inc. (U.S.), and others.
Drivers and Constraints Impacting the Market
With
the growing prevalence of chronic renal diseases and blood-related diseases,
the global apheresis
market is considered to stimulate during the estimated period.
Increasing complex surgical procedures, rising demand for different component
of blood, and growing number of accidents across the globe are considered to
augment the market growth in the coming years. Demand for platelets and plasma
has also increased which is further impacting the global market positively.
Moreover, with continuous advancement in technology and growing need for
advanced and automated devices, the market is likely to foster.
On
the flip side, high cost of procedures and lack of skilled professionals are
some of the major factors considered to impede the market growth in the coming
years.
Global Apheresis Market: Segmental Analysis
The
global apheresis market has been segmented on the basis of product, procedure,
methods, application, end-users, and region.
By
mode of product, global apheresis market has been segmented into devices and
disposables. The devices segment has been further sub-segmented into platelets
separators, plasma separators, and others.
By
mode of procedure, the global apheresis market has been segmented into
leukapheresis, plateletpheresis, plasmapheresis, erythrocytapheresis, and
others.
By
mode of methods, the global apheresis market has been segmented into filtration
and centrifugation. Among these, centrifugation is further sub-segmented into
intermittent flow centrifugation, continuous flow centrifugation, and others.
By
mode of application, the global apheresis market has been segmented into
oncological diseases, immunological diseases, hematological diseases,
cardiovascular diseases, renal diseases, neurological diseases, and others.
By
mode of end-users, the global apheresis market has been segmented into
hospitals, blood banks, and others.
Regional Insights
Geographically,
apheresis market span across regions namely, America, Europe, Asia Pacific, and
Rest-of-the-World (RoW).
Among
all the regions, America is considered to hold the largest position in the
global market and is expected to maintain its dominance during the assessment
period. The growth is attributed to the advancement in technology and growing
opportunity for apheresis products coupled with the presence of a huge patient
population suffering from chronic diseases.
Asia
Pacific is considered to be the fastest growing region in the global market
owing to the growing demand for blood components for patients. Moreover, rapid
development in the healthcare industry along with growing expenditure on health
care is considered to contribute to the growth of the global market.
For more information, Please Visit us @ Market
Research Future
No comments:
Post a Comment